141 related articles for article (PubMed ID: 19513837)
21. Effect of a gastrin/cholecystokinin B receptor antagonist, S-0509, on the omeprazole-induced proliferation of gastric mucosa in rats.
Ono M; Sato H; Kazumori H; Yuki M; Rumi MA; Ortega-Cava CF; Ishihara Y; Ishihara S; Adachi K; Kinoshita Y
J Lab Clin Med; 2003 Dec; 142(6):364-71. PubMed ID: 14713888
[TBL] [Abstract][Full Text] [Related]
22. Correlation between acid secretion and proton pump activity during inhibition by the proton pump inhibitors omeprazole and pantoprazole.
Nishioka K; Nagao T; Urushidani T
Biochem Pharmacol; 1999 Oct; 58(8):1349-59. PubMed ID: 10487539
[TBL] [Abstract][Full Text] [Related]
23. Pharmacokinetic drug interaction profiles of proton pump inhibitors.
Blume H; Donath F; Warnke A; Schug BS
Drug Saf; 2006; 29(9):769-84. PubMed ID: 16944963
[TBL] [Abstract][Full Text] [Related]
24. Molecular characterization of rat gastric mucosal response to potent acid inhibition.
Nørsett KG; Laegreid A; Langaas M; Wörlund S; Fossmark R; Waldum HL; Sandvik AK
Physiol Genomics; 2005 Jun; 22(1):24-32. PubMed ID: 15827235
[TBL] [Abstract][Full Text] [Related]
25. Effects of omeprazole and ranitidine on plasma gastrin concentration and stomach gastrin content in rats.
Seensalu R; Girma K; Romell B; Nilsson G
Ups J Med Sci; 1992; 97(2):157-67. PubMed ID: 1471315
[TBL] [Abstract][Full Text] [Related]
26. Gastroprotective activities of Turnera diffusa Willd. ex Schult. revisited: Role of arbutin.
Taha MM; Salga MS; Ali HM; Abdulla MA; Abdelwahab SI; Hadi AH
J Ethnopharmacol; 2012 May; 141(1):273-81. PubMed ID: 22374081
[TBL] [Abstract][Full Text] [Related]
27. Induction of tumor necrosis factor-alpha and apoptosis in gastric mucosal injury by indomethacin: effect of omeprazole and ebrotidine.
Slomiany BL; Piotrowski J; Slomiany A
Scand J Gastroenterol; 1997 Jul; 32(7):638-42. PubMed ID: 9246701
[TBL] [Abstract][Full Text] [Related]
28. Comparative pharmacokinetic/pharmacodynamic study of proton pump inhibitors, omeprazole and lansoprazole in rats.
Katashima M; Yamamoto K; Sugiura M; Sawada Y; Iga T
Drug Metab Dispos; 1995 Jul; 23(7):718-23. PubMed ID: 7587960
[TBL] [Abstract][Full Text] [Related]
29. Effect of a gastrin-releasing peptide receptor antagonist and a proton pump inhibitor association in an animal model of gastritis.
Petronilho F; Araújo JH; Steckert AV; Rezin GT; Ferreira GK; Roesler R; Schwartsmann G; Dal-Pizzol F; Streck EL
Peptides; 2009 Aug; 30(8):1460-5. PubMed ID: 19505518
[TBL] [Abstract][Full Text] [Related]
30. Effect of the histamine-1 antagonist astemizole alone or with omeprazole on rat gastric mucosa.
Waldum HL; Lehy T; Brenna E; Sandvik AK; Petersen H; Søgnen BS; Bonfils S; Lewin MJ
Scand J Gastroenterol; 1991 Jan; 26(1):23-35. PubMed ID: 1706533
[TBL] [Abstract][Full Text] [Related]
31. Effects of omeprazole treatment on nucleoside transporter expression and adenosine uptake in rat gastric mucosa.
Redzic ZB; Hasan FA; Al-Sarraf H
Can J Physiol Pharmacol; 2009 May; 87(5):402-10. PubMed ID: 19448739
[TBL] [Abstract][Full Text] [Related]
32. Effects of omeprazole on ethanol lesions.
Abdel Fattaha NA; Abdel-Rahman MS
Toxicol Lett; 2000 Dec; 118(1-2):21-30. PubMed ID: 11137305
[TBL] [Abstract][Full Text] [Related]
33. [Effect of long-term administration of antisecretary drugs on rat gastric histamine synthesis and acid secretion--compare with omeprazole and cimetidine].
Morita R; Harasawa S; Miwa T; Matsumoto M
Nihon Shokakibyo Gakkai Zasshi; 1992 Oct; 89(10):2551-8. PubMed ID: 1404968
[TBL] [Abstract][Full Text] [Related]
34. [Omeprazole and liver functions].
Sauvet P; Schouler L
Rev Med Interne; 1992; 13(5):359-63. PubMed ID: 1344831
[TBL] [Abstract][Full Text] [Related]
35. The effect of changes in gastric pH induced by omeprazole on the absorption and respiratory depression of methadone.
de Castro J; Aguirre C; Rodríguez-Sasiaín JM; Gómez E; Garrido MJ; Calvo R
Biopharm Drug Dispos; 1996 Oct; 17(7):551-63. PubMed ID: 8894114
[TBL] [Abstract][Full Text] [Related]
36. Omeprazole, lansoprazole and pantoprazole had no effect on blood pressure and electrocardiogram of anesthetized rat.
Yenişehirli A; Naseri E
Pharmacol Res; 2008 Jul; 58(1):65-71. PubMed ID: 18647653
[TBL] [Abstract][Full Text] [Related]
37. Reversible inhibition of rat gastric H+/K+-ATPase by T-330, 2-[2-dimethylaminobenzyl)sulfinyl]-1-(3-methylpyridine-2-yl)imidazole.
Kinoshita M; Saito N; Noto T; Tamaki H
J Pharmacol Exp Ther; 1996 Apr; 277(1):28-33. PubMed ID: 8613931
[TBL] [Abstract][Full Text] [Related]
38. Protective effects of sucralfate and omeprazole on gastric mucosal damage induced by ethanol in rats.
Kaya N; Boyunapa H; Baris S; Kahraman H; Altintop L
Wien Klin Wochenschr; 1998 Feb; 110(3):96-100. PubMed ID: 9553204
[TBL] [Abstract][Full Text] [Related]
39. A potential drug combination of omeprazole and patchouli alcohol significantly normalizes oxidative stress and inflammatory responses against gastric ulcer in ethanol-induced rat model.
Xie L; Guo YL; Chen YR; Zhang LY; Wang ZC; Zhang T; Wang B
Int Immunopharmacol; 2020 Aug; 85():106660. PubMed ID: 32559721
[TBL] [Abstract][Full Text] [Related]
40. [The effect of omeprazole, a proton pump inhibitor, on ontogeny of rat gastric mucosa, with special reference to cell proliferation and DNA synthesis].
Kawai T; Kawai K; Inokuchi H; Azuma T; Sasaki Z; Seki T; Harada Y; Saito T
Nihon Shokakibyo Gakkai Zasshi; 1987 Jul; 84(7):1381-8. PubMed ID: 3682234
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
